Neurology

Back to articles

Levodopa phobia? Study shows fears unfounded

KEY POINT

Choice of initial therapy with either a dopamine agonist, levodopa, or monoamine oxidase (MAO) type B inhibitor in patients with early Parkinson’s disease (PD) results in similar patient-rated mobility quality of life over the long term.